Researchers retrospectively analyzed data of 5,879 heart attack patients at 21 community hospitals admitted over 27 months. Approximately 60 percent of those patients (3,531) were treated using AMI-OS.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
Fifty percent of AMI-OS treated patients received all five evidence-based therapies indicated in the AMI-OS (aspirin, beta blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, anticoagulation therapy and statins). Only 35.9 percent of patients receiving individually ordered, or “a la carte,” treatments received all five therapies.
The patients treated using AMI-OS experienced a 46 percent lower in-hospital mortality rate than patients receiving individual treatments (3.51 percent vs. 6.52 percent) and a 33 percent lower 30-day mortality rate (5.66 percent vs. 8.48 percent).
Researchers suggest using the electronic order set improves adherence to evidence-based care, as well as better patient outcomes.
More Articles on Quality:
Study: Diabetes, Age Predict Cardiovascular Procedure Complications
High Transfer Rates Not Associated With Higher Mortality
When Crossing Boundaries Helps Patients Stay Healthy
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
